-
Iobenguane
- names:
2-[(3-iodophenyl)methyl]guanidine
- CAS号:
139755-80-9
MDL Number: - MF(分子式): C8H10IN3 MW(分子量): 275.0896
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | Iobenguane |
| 英文别名 | Iobenguane, Adreview, Metaiodobenzylguanidine |
| CAS号 | 139755-80-9 |
| Inchi | InChI=1S/C8H10IN3/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5H2,(H4,10,11,12) |
| InchiKey | PDWUPXJEEYOOTR-UHFFFAOYSA-N |
| 分子式 Formula | C8H10IN3 |
| 分子量 Molecular Weight | 275.0896 |
| 溶解度Solubility | |
| 性状 | Solid powder |
| 储藏条件 Storage conditions | Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years). |
| 产品说明 | Iobenguane(CAS:139755-80-9):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。 |
| Introduction | Iobenguane is a radiopharmaceutical, used in a scintigraphy method called MIBG scan. Iobenguane is a radiolabeled molecule similar to noradrenaline. It localizes to adrenergic tissue and thus can be used to identify the location of tumors such as phaeochromocytomas and neuroblastomas. With I-131 it can also be used to eradicate tumor cells that take up and metabolize norepinephrine. |
| Application1 | |
| Application2 | |
| Application3 |
| [1]Feola M, Chauvie S, Biggi A, Testa M. Role of (123)I-Iobenguane Myocardial Scintigraphy in Predicting Short-term Left Ventricular Functional Recovery: An Interesting Image. J Clin Imaging Sci. 2015 Oct 30; |
| 5:56. doi: 10.4103/2156-7514.168707. eCollection 2015. PubMed PMID: 26664773; PubMed Central PMCID: PMC4647125. |
| [3]Chin BB, Kronauge JF, Femia FJ, Chen J, Maresca KP, Hillier S, Petry NA, James OG, Oldan JD, Armor T, Stubbs JB, Stabin MG, Babich JW. Phase-1 clinical trial results of high-specific-activity carrier-free 123I-iobenguane. J Nucl Med. 2014 May;55(5):765-71. doi: 10.2967/jnumed.113.124057. Epub 2014 Mar 13. PubMed PMID: 24627436. |
| [4]Coleman RE, Stubbs JB, Barrett JA, de la Guardia M, Lafrance N, Babich JW. Radiation dosimetry, pharmacokinetics, and safety of ultratrace Iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid. Cancer Biother Radiopharm. 2009 Aug;24(4):469-75. doi: 10.1089/cbr.2008.0584. PubMed PMID: 19694582. |
| [5] Cortés-Blanco A, Martínez Lázaro R, Vargas Castrillón E. [Authorized specifications for human use in clinical practice of radiopharmaceuticals composed of iobenguane (123I) marketed in Spain]. Rev Esp Med Nucl. 2008 Nov-Dec;27(6):468-74. Spanish. PubMed PMID: 19094909. |
5: Hinkle GH, Dura JV, Morosco RS, Nahata MC. Extended stability of iobenguane under simulated clinical conditions. Am J Health Syst Pharm. 2008 Jan 15;65(2):142-4. doi: 10.2146/ajhp070247. PubMed PMID: 18192259.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


